Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

INDUSTRY × Basal Cell Nevus Syndrome × gusacitinib × Clear all

Phase

Status

Suspended 1 Completed 1

Sponsor Class

Study Type

Interventional 2

Sponsor

Cancer Type

Conditions

Basal Cell Nevus Syndrome 2 Skin Neoplasms 1 Carcinoma, Basal Cell 1

Interventions

IPI-926 3 sonidegib 2 gusacitinib 2 Drug Evaluation 2 Fluorouracil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03208296 2023-02-06

Study of ASN-002 to Treat Basal Cell Carcinomas (BCCs) in Individuals With Basal Cell Nevus Syndrome (BCNS)

Ascend Biopharmaceuticals Ltd

Phase 1/2 Suspended

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell

NCT02550678 2018-06-06

ASN-002-001

Ascend Biopharmaceuticals Ltd

Phase 1/2 Completed

Basal Cell Nevus Syndrome, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡